These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12687550)

  • 1. Treatment of systemic lupus erythematosus-associated type B insulin resistance syndrome with cyclophosphamide and mycophenolate mofetil.
    Gehi A; Webb A; Nolte M; Davis J
    Arthritis Rheum; 2003 Apr; 48(4):1067-70. PubMed ID: 12687550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil: a magic bullet for lupus?
    McCune WJ; Riskalla MM
    J Rheumatol; 2005 Jun; 32(6):967-70. PubMed ID: 15940751
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus.
    Mak A; Mok CC
    Lupus; 2005; 14(10):856-8. PubMed ID: 16302683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in immune cell frequencies after cyclophosphamide or mycophenolate mofetil treatments in patients with systemic lupus erythematosus.
    Zhao L; Jiang Z; Jiang Y; Ma N; Wang K; Zhang Y
    Clin Rheumatol; 2012 Jun; 31(6):951-9. PubMed ID: 22349930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric Systemic Lupus Erythematosus with Cerebral Vasculitis and Lupus Nephritis Successfully Treated with High-dose Glucocorticoids and Mycophenolate Mofetil.
    Tanaka S; Kawaguchi T; Kudo R; Kimura M; Rikitake Y; Iwao C; Rikitake M; Iwao K; Aizawa A; Kariya Y; Matsuda M; Miyauchi S; Takajo I; Umekita K
    Intern Med; 2022 Oct; 61(20):3131-3135. PubMed ID: 35283391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil and systemic lupus erythematosus: an overview.
    Pisoni CN; Karim Y; Cuadrado MJ
    Lupus; 2005; 14 Suppl 1():s9-11. PubMed ID: 15803925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil as a maintenance therapy for lupus-related diffuse alveolar hemorrhage: a case report.
    Al Rashidi A; Alajmi M; Hegazi MO
    Lupus; 2011 Dec; 20(14):1551-3. PubMed ID: 21828160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents.
    Karim MY; Alba P; Cuadrado MJ; Abbs IC; D'Cruz DP; Khamashta MA; Hughes GR
    Rheumatology (Oxford); 2002 Aug; 41(8):876-82. PubMed ID: 12154204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.
    Kizawa T; Nozawa T; Kikuchi M; Nagahama K; Okudela K; Miyamae T; Imagawa T; Nakamura T; Mori M; Yokota S; Tsutsumi H
    Mod Rheumatol; 2015 Mar; 25(2):210-4. PubMed ID: 25159157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil as a treatment for autoimmune haemolytic anaemia in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Alba P; Karim MY; Hunt BJ
    Lupus; 2003; 12(8):633-5. PubMed ID: 12945724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.
    Ginzler EM; Wofsy D; Isenberg D; Gordon C; Lisk L; Dooley MA;
    Arthritis Rheum; 2010 Jan; 62(1):211-21. PubMed ID: 20039429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil].
    Sixdorf U; Bauer H; Märker-Hermann E
    Dtsch Med Wochenschr; 2006 Oct; 131(41):2266-9. PubMed ID: 17036267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune myelofibrosis with pancytopenia as a presenting manifestation of systemic lupus erythematosus responsive to mycophenolate mofetil.
    Ungprasert P; Chowdhary VR; Davis MD; Makol A
    Lupus; 2016 Apr; 25(4):427-30. PubMed ID: 26537421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic lupus erythematosus.
    D'Cruz DP; Khamashta MA; Hughes GR
    Lancet; 2007 Feb; 369(9561):587-96. PubMed ID: 17307106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a multitarget therapy with prednisolone, mycophenolate mofetil, and tacrolimus in a patient with type B insulin resistance syndrome complicated by lupus nephritis.
    Temmoku J; Asano T; Saito K; Matsumoto H; Fujita Y; Furuya-Yashiro M; Matsuoka N; Oda A; Tanabe H; Sato S; Shio-Yano K; Sasajima T; Kiko Y; Kobayashi H; Watanabe H; Shimabukuro M; Migita K
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):41-46. PubMed ID: 34651654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium haemophilum infection in an SLE patient on mycophenolate mofetil.
    Teh CL; Kong KO; Chong AP; Badsha H
    Lupus; 2002; 11(4):249-52. PubMed ID: 12043889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress and perspectives in the treatment of systemic lupus erythematosus].
    Robak E; Sysa-Jedrzejowska A; Wozniacka A
    Przegl Lek; 2005; 62(9):894-9. PubMed ID: 16541725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of severe refractory lupus hepatitis with mycophenolate mofetil.
    Tagawa Y; Saito T; Takada K; Kawahata K; Kohsaka H
    Lupus; 2016 Apr; 25(5):543-6. PubMed ID: 26762472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil for non-renal manifestations of systemic lupus erythematosus: a systematic review.
    Mok CC
    Scand J Rheumatol; 2007; 36(5):329-37. PubMed ID: 17963161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.